Orchid receives USFDA approval for Venlafaxine ER Capsules

14 Jul 2011 Evaluate

Orchid Chemicals & Pharmaceuticals (Orchid), the Chennai-based pharma major, has received approval from the USFDA for its ANDA (Abbreviated New Drug Application) for Venlafaxine Extended Release (ER) Capsules in the 37.5 mg, 75 mg and 150 mg strengths.

Recently, the company was in active dialogue with the Tamil Nadu Pollution Control Board (TNPCB) officials and was confident of resolving the issues and bringing the plant to a fully operational stage at the earliest. Earlier, the company’s Cephalosporin API manufacturing facility located in Alathur at Chennai was issued a closure notice by the TNPCB citing some non-compliance with regard to the disposal of solid waste.

Orchid Chemicals & Pharmaceuticals (Orchid) is a pharmaceutical company engaged in development and manufacture of active pharmaceutical ingredients (APIs) and finished dosage forms. It is also engaged in research of new drugs. The company was incorporated in the year 1992 as a 100% export-oriented unit (EOU).

Orchid Pharma Share Price

1062.50 -14.35 (-1.33%)
19-Apr-2024 16:01 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1525.00
Dr. Reddys Lab 5942.65
Cipla 1345.35
Zydus Lifesciences 925.95
Lupin 1547.05
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt.Ltd.